The global wearable patches market was valued at $10,462.4 million in 2022 and is expected to reach $26,892.7 million by 2031, growing at a CAGR of 10.19% between 2023 and 2031.
The global scar management market was valued at $1,040.1 million in 2022 and is anticipated to reach $1,594.4 million by 2030, witnessing a CAGR of 5.53% during the forecast period 2023-2030.
The global wound cleanser market was valued at $1,873.4 million in 2022 and is expected to reach $2,434.3 million by 2030, growing at a CAGR of 3.34% between 2023 and 2030.
The global laboratory automation market was valued at $9.17 billion in 2022 and is anticipated to reach $24.84 billion by 2033, witnessing a CAGR of 9.57% during the forecast period 2023-2033.
The global gene fusion testing market was valued at $255.3 million in 2022 and is anticipated to reach $897.6 million by 2033, witnessing a CAGR of 12.25% during the forecast period 2023-2033.
Need reports on an on-going basis? Do consider our annual subscription
The global cell and gene therapy biomanufacturing CDMO market - focused on AAV was valued at $231.3 million in 2022 and is anticipated to reach $2,566.6 million by 2033, witnessing a CAGR of 24.61% during the forecast period 2023-2033.
The global rare disease genetic testing market was valued at $4.11 billion in 2022 and is anticipated to reach $16.69 billion by 2033, witnessing a CAGR of 13.69% during the forecast period 2023-2033.
The global cardiac AI monitoring and diagnostics market was valued at $1,010.5 million in 2022 and is anticipated to reach $10,666.5 million by 2032, witnessing a CAGR of 26.88% during the forecast period 2023-2032.
The next-generation IVD market was valued at $86.21 billion in 2022 and is expected to reach $152.62 billion by 2033, growing at a CAGR of 5.41% between 2023 and 2033.
The global emerging infectious disease diagnostics market was valued at $19.56 billion in 2022 and is expected to reach $37.21 billion by 2033, growing at a CAGR of 6.19% between 2023 and 2033.
The global EV-based liquid biopsy market was valued at $78.22 million in 2022 and is anticipated to reach $455.53 million by 2032, witnessing a CAGR of 19.73% during the forecast period 2023-2032.
The global acute care syndromic testing market was valued at $3.14 billion in 2022 and is expected to reach $8.44 billion by 2033, growing at a CAGR of 9.43% between 2023 and 2033.
The global biomanufacturing viral detection and quantification market was valued at $474.3 million in 2022 and is anticipated to reach $1,149.7 million by 2032, witnessing a CAGR of 9.37% during the forecast period 2023-2032.
The global cell and gene therapy manufacturing QC market was valued at $1.95 billion in 2022 and is anticipated to reach $10.65 billion by 2033, witnessing a CAGR of 16.85% during the forecast period 2023-2033.
The global MRD testing market is projected to reach $6.67 billion by 2033 from $1.47 billion in 2022, growing at a CAGR of 14.81% during the forecast period 2023-2033.
The global NGS market was valued at $6.76 billion in 2022 and is expected to reach $28.47 billion by 2033, growing at a CAGR of 13.97% during the forecast period 2023-2033.
The global contrast media agent and injector system market was valued at $7,634.6 million in 2022 and is expected to reach $9,712.3 million by 2026, growing at a CAGR of 6.20% during the forecast period 2022-2026.
The global colorectal cancer screening and diagnostic market was valued at $15.28 billion in 2022 and is expected to reach $28.52 billion by 2033, growing at a CAGR of 5.93% during the forecast period 2023-2033.
The global constrained peptide drugs market is expected to reach $17.38 billion in 2040 from $0.06 billion in 2024, growing at a CAGR of 38.94% during the forecast period 2025-2040.
The global single-cell multi-omics market is projected to reach $7.72 billion by 2033 from $1.43 billion in 2022, growing at a CAGR of 17.27% during the forecast period 2023-2033.
The global NGS data storage market is projected to reach $6.96 billion by 2033 from $1.13 billion in 2022, growing at a CAGR of 18.02% during the forecast period 2023-2033.
In 2022, the global functional genomics market was valued at $10.57 billion, and it is expected to reach $46.24 billion by 2033, growing at a CAGR of 14.04% during the forecast period 2023-2033.
The global next-generation breast cancer diagnostic and screening market was valued at $3,137.4 million in 2022 and is anticipated to reach $9,880.1 million by 2032.
The global gene editing technologies market was valued at $1.81 billion in 2022 and is anticipated to reach $16.37 billion by 2032, witnessing a CAGR of 27.50% during the forecast period 2023-2032.
In 2022, the global organ transplant diagnostics market was valued at $4.03 billion and is expected to reach $11.78 billion by 2033, with a CAGR of 10.45% during the forecast period 2023-2033.
The global cell-based assay market is expected to reach $38.23 billion in 2032 from $17.20 billion in 2022, at a CAGR of 8.44% during the forecast period 2023-2032.
The global multicancer screening market is projected to reach $7.78 billion by 2032 from $1.90 billion in 2022, growing at a CAGR of 15.09% during the forecast period 2023-2032.
The global nucleic acid therapeutics CDMO market was valued at $3.88 billion in 2022 and is expected to reach $14.19 billion by 2033, growing at a CAGR of 12.55% during the forecast period 2023-2033.
The global minimally invasive spine technologies market was valued at $3,180.9 million in 2022 and is anticipated to reach $9,406.5 million by 2032, witnessing a CAGR of 11.45% during the forecast period 2022-2032.
The Asia-Pacific and Middle East NGS market was valued at $1,055.6 million in 2022 and is anticipated to reach $2,370.7 million by 2027, witnessing a CAGR of 17.56% during the forecast period 2022-2027.
The global artificial intelligence/machine learning medical device market was valued at $4,011.7 million in 2022 and is anticipated to reach $35,458.2 million by 2032, witnessing a CAGR of 24.35% during the forecast period 2022-2032.
The global deep venous disease treatment devices market was valued at $1,119.3 million in 2022 and is anticipated to reach $2,419.2 million by 2032, witnessing a CAGR of 7.72% during the forecast period 2023-2032.
The global dry X-Ray film market was valued at $924.7 million in 2022 and is anticipated to reach $1,112.2 million by 2032, witnessing a CAGR of 1.86% during the forecast period 2022-2032.
The global AI-enabled medical imaging solutions market was valued at $1,854.5 million in 2022 and is anticipated to reach $18,356.5 million by 2032, witnessing a CAGR of 25.76% during the forecast period 2022-2032.
The global surgical robotics market was valued at $8,705.3 million in 2022 and is anticipated to reach $18,410.9 million by 2032, witnessing a CAGR of 7.78% during the forecast period 2022-2032.
The global cell and gene therapy biomanufacturing market was valued at $12.31 billion in 2022 and is anticipated to reach $29.76 billion by 2031, witnessing a CAGR of 10.31% during the forecast period 2022-2031.
The global medical X-Ray detectors market was valued at $2,167.0 million in 2022 and is anticipated to grow to $3,702.0 million by the end of 2032, at a projected CAGR of 5.50% during the forecast period 2022-2032.
The U.S. DTC wellness testing market is projected to reach $4,946.3 million by 2032 from $878.9 million in 2022, at a CAGR of 18.86% during the forecast period 2022-2032.
The U.S. orthopedic imaging modalities market was valued at $2,697.8 million in 2022 and is anticipated to grow to $3,989.9 million by the end of 2031, at a projected CAGR of 4.44% during the forecast period 2022-2031.
The global targeted sequencing market is projected to reach $10,976.1 million by 2032 from $3,198.8 million in 2022, growing at a CAGR of 13.12% during the forecast period 2022-2032.
The global nucleic acid sample preparation market is projected to reach $11,200.5 million by 2032 from $4,213.0 million in 2022, growing at a CAGR of 10.27% during the forecast period 2022-2032.
The U.S. women health laboratory testing market was valued at $72.8 billion in 2021 and is anticipated to reach $106.8 billion by 2030, witnessing a CAGR of 4.30% during the forecast period 2022-2030.
The global NGS informatics market was valued at $1,380.0 million in 2021 and is projected to reach $6,715.0 million by the end of 2032.
The U.S. prostate cancer testing market is anticipated to reach $1,901.6 million in 2030 from $544.1 million in 2021, with a CAGR of 14.7%, during the forecast period 2022-2030.
In 2021, the global prostate cancer testing market was valued at $5,246.9 million, and it is expected to reach $21,306.9 million by 2032, growing at a CAGR of 13.68% during the forecast period 2022-2032.
The global wearable patches market was valued at $8,650.0 million in 2021 and is projected to reach $26,892.7 million by the end of 2031.
The global radiation dose management market was valued at $212.8 million in 2021 and is anticipated to reach $586.7 million by 2032, witnessing a CAGR of 10.30% during the forecast period 2022-2032.
The report focuses solely on the extensive stage small cell lung cancer treatment, which includes approved products as well as products under clinical development.
The global molecular oncology diagnostics market was valued at $3,620.6 million in 2021 and is anticipated to reach $12,130.5 million by 2032, witnessing a CAGR of 11.43% during the forecast period 2022-2032.
The U.S. hereditary genetic testing market was valued at $7.57 billion in 2021 and is forecasted to reach $29.28 billion by 2032.
The global flow cytometry in oncology and immunology market was valued at $1,653.2 million in 2021 and is anticipated to reach $5,287.4 million by 2032, witnessing a CAGR of 11.39% during the forecast period 2022-2032.
The global laboratory informatics market was valued at $4,341.2 million in 2021 and is anticipated to reach $12,677.0 million by 2032, witnessing a CAGR of 10.27% during the forecast period 2022-2032.
In 2021, the global NGS kits market was valued at $4,553.6 million, and it is expected to reach $26,057.4 million by 2032, growing at a CAGR of 17.27% during the forecast period 2022-2032.
The Middle East and North Africa laparoscopy devices market was valued at $752.0 million in 2021 and is anticipated to reach $1,731.4 million by 2031, witnessing a CAGR of 7.71% during the forecast period 2022-2031.
The Canada laparoscopy devices market was valued at $392.1 million in 2021 and is anticipated to reach $865.6 million by 2031, witnessing a CAGR of 7.31% during the forecast period 2022-2031.
The global ambulatory surgical center operating room integration systems market is projected to reach $5,668.2 million by 2032 from $2,077.5 million in 2021, at a CAGR of 9.88% during the forecast period 2022-2032.
The global phosphoramidite market is projected to reach $2,062.9 million by 2032 from $900.3 million in 2021, at a CAGR of 7.78% during the forecast period 2022-2032.
In 2021, the global 3D protein structure analysis market was valued at $1,017.2 million, and it is expected to reach $2,676.6 million by 2032, growing at a CAGR of 9.32% during the forecast period 2022-2032.
The global market for serum-free media was valued at $1,022.4 million in 2021 and is expected to reach $3,920.5 million by 2032, registering a CAGR of 12.73% during the forecast period 2022-2032.
The global gastrointestinal endoscopy market was valued at $13.40 billion in 2021 and is anticipated to reach $25.75 billion by 2031, witnessing a CAGR of 6.24% during the forecast period 2022-2031.
In 2021, the global NGS library preparation automation market was valued at $1,273.2 million, and it is expected to reach $3,803.3 million by 2029, growing at a CAGR of 14.85% during the forecast period 2022-2029.
The report provides an exhaustive list of pipeline products which are currently in the development along with their developmental details in various indications.
The global cell-free RNA isolation and extraction kits market is projected to reach $140.7 million by 2032 from $30.2 million in 2021, growing at a CAGR of 14.98% during the forecast period 2022-2032.
The market size of MR imaging in neurosurgery was valued at $88.7 million in 2021 and is anticipated to reach $150.5 million by the end of 2031, registering a CAGR of 5.52% during the forecast period 2022-2031.
The global FLT3 inhibitors market is expected to reach $2,061.3 million in 2032 from $400.9 million in 2021 at a CAGR of 14.88% during the forecast period 2022-2032.
The global recombinant cell culture supplements market was estimated at $308.6 million in 2021 and is expected to reach $1,188.6 million by 2032, growing at a CAGR value of 12.24% during the forecast period 2022-2032.
The global pharmaceutical aseptic transfer market is projected to reach $2,551.5 million by 2031 from $855.2 million in 2021 at a CAGR of 9.61% during the forecast period 2022-2031.
The global digital PCR market is projected to reach $2,847.8 million by 2032 from $441.2 million in 2021, at a CAGR of 18.73% during the forecast period 2022-2032.
In 2021, the global clinical biomarkers market was valued at $21,304.3 million, and it is expected to reach $54,294.0 million by 2032, growing at a CAGR of 8.73% during the forecast period 2022-2032.
The global hyperspectral imaging market was estimated to be at $791.2 million in 2021, which is expected to grow with a CAGR of 13.17% and reach $1,640.3 million by 2027.
The global narcolepsy therapeutics market is projected to reach $4,912.3 million by 2032 from $915.2 million in 2021 at a CAGR of 15.93% during the forecast period 2022-2032.
The global human identification market is projected to reach $6,435.6 million by 2032 from $1,385.8 million in 2021, at a CAGR of 14.77% during the forecast period 2022-2032.
The global ligase market is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032.
The global laparoscopy and endoscopy devices market was valued at $23,809.2 million in 2021 and is projected to reach $38,942.2 million by the end of 2031, growing at a CAGR of 4.94% during the forecast period 2022-2031.
In 2021, the global microbiome therapeutics market valued $306.3 million, and it is estimated to reach $3,204 million by 2032, registering a CAGR of 24.95% during the forecast period 2022-2032.
The global NK cell therapeutics market is expected to reach $5,676.1 million in 2032 from $297.2 million in 2024 at a CAGR of 44.59% during the forecast period 2024-2032.
The global endoscopic imaging systems market was valued at $3,641.3 million in 2021 and is projected to reach $6,941.3 million by 2030.
The global NGS oncology market is projected to reach $51,783.0 million in 2032 from 14,828.6 million in 2021, witnessing a CAGR of 12.04% during the forecast period 2022-2032.
The global hematologic malignancies testing market is projected to reach $11,680.1 million by 2032, growing from $2,606.5 million in 2021, at a CAGR of 14.23% during the forecast period 2022-2032.
The global next-generation oncology devices and solutions market was valued at $3,268.2 million in 2021 and is projected to reach $5,971.3 million by 2031.
The market size of digital biomanufacturing was valued at $15,768.9 million in 2021 and is anticipated to reach $55,564.9 million by the end of 2031, registering a CAGR of 13.12% during the forecast period 2022-2031.
The minimal residual disease (MRD) testing market is projected to reach $2,611.2 million by 2027 from $1,089.3 million in 2021, at a CAGR of 14.53%.
The U.S. solid tumor testing market is projected to reach $18,287.6 million by 2032 from $9,498.8 million in 2021, at a CAGR of 6.19% during the forecast period 2022-2032.
The Middle East molecular diagnostics market is projected to reach $1,017.7 million by 2031 from $493.1 million in 2020, at a CAGR of 6.72% during the forecast period 2021-2031.
The global liquid biopsy market is projected to reach $19,066.0 million by 2032 from $2,508.2 million in 2021 at a CAGR of 19.83% during the forecast period 2022-2032.
In 2021, the Middle East liquid biopsy market was valued at $43.7 million, and it is expected to reach $175.2 million by 2032, growing at a CAGR of 13.68% during the forecast period 2022-2032.
The lung cancer genomic testing medicine market was valued at $1,262.0 million in 2020 and is expected to reach $3,279.8 million by 2031, growing at a CAGR of 8.97% during the forecast period 2021-2031.
In 2021, the Middle East precision medicine market was valued at $3,942.6 million, and it is expected to reach $8,620.0 million by 2032, growing at a CAGR of 7.37% during the forecast period 2022-2032.
In 2021, the global axial spondyloarthritis market was valued at $1,873.8, which is expected to reach $7,937.8 million in 2032 by witnessing a growing CAGR of 13.44% during the forecast period, 2022-2032.
The global blood and plasma components market is projected to reach $66.47 billion in 2031 from $39.58 billion in 2020, witnessing a CAGR of 4.90% during the forecast period 2021-2031.
The market size of digital biomarkers was valued at $1,808.3 million in 2021 and is anticipated to reach $16,174.0 million by the end of 2028, registering a CAGR of 36.06% during the forecast period 2022-2028.
In 2020, the global single cell bioinformatics software and services market was valued at $205.2 million, and it is expected to reach $634.8 million by 2031, growing at a CAGR of 10.89% during the forecast period 2021-2031.
The Europe infectious disease diagnostics market is projected to reach $7,900.4 million by 2031 from $1,394.3 million in 2020, at a CAGR of 16.48% during the forecast period 2021-2031.
The single cell RNA sequencing market is anticipated to reach a value of $2,931.3 million in 2031 from $386.7 million in 2020, witnessing a CAGR of 17.08% during the forecast period 2021-2031.
The global operating room management solutions market was valued at $2,023.5 million in 2021 and is anticipated to reach $3,699.1 million by the end of 2031, registering a CAGR of 6.29% during the forecast period 2022-2031.
The report contains the analysis of variables such as recent trends, technological advancements, and international level initiatives across the globe influencing the adoption of acellular therapy.
The global gene cloning services market was valued at $1,983.6 million in 2020 and is expected to reach $11,524.4 million by 2031, growing at a CAGR of 17.29% during the forecast period 2021-2031.
The global big data in healthcare market was valued at $32,925.1 million in 2021 and is anticipated to reach $130,132.1 million by the end of 2031, registering a CAGR of 13.96% during the forecast period 2022-2031.
The global radioligand therapy market is projected to reach $16,658.4 million by 2031, growing from $9,754.9 million in 2020, at a CAGR of 4.67% during the forecast period 2021-2031.
The report constitutes a strategical information and implementation for the plasma medicine market.
The global capillary electrophoresis market was valued at $318.3 million in 2020 and is expected to reach $586.9 million by 2031, growing at a CAGR of 5.66% during the forecast period 2021-2031.
In 2020, the global next-generation gynecological cancer diagnostics market was valued at $1,976.5 million, which is expected to reach $5,657.7 million by 2031, growing at a CAGR of 10.07% during the forecast period 2021-2031.
The global operating room (OR) integration systems market was valued at $11,763.6 million in 2021 and is projected to reach $21,546.1 million by the end of 2031.
The global oncology precision medicine market was valued at $45,174.2 million in 2020 and is expected to reach $1,28,891.6 million by 2031, growing at a CAGR of 10.05% during the forecast period 2021-2031.
The global dental radiography market was valued at $2,328.5 million in 2021 and is projected to reach $3,914.8 million by the end of 2031.
In 2020, the global hematological malignancies emerging therapeutics market was valued at $8,444.8 million, which is expected to reach $43,966.8 million in 2031.
The global minimally invasive surgical systems market is estimated to be valued at $27,882.8 million in 2020 and is anticipated to reach $55,716.7 million by the end of 2031, growing at a CAGR of 6.3% during 2021-2031.
The global precision cardiology market is projected to reach $3,584.6 million by 2031 from $956.6 million in 2020, at a CAGR of 12.90% during the forecast period 2021-2031.
The global brain disease modalities and software market was valued at $13,055.7 million in 2021 and is projected to reach $21,867.6 million by the end of 2031.
The global brain imaging modalities market was valued at $12,334.2 million in 2021 and is projected to reach $20,209.2 million by the end of 2031.
The in-silico drug discovery market is projected to reach $10,409.9 million by 2031 from $1,619.6 million in 2020, at a CAGR of 18.47% in the forecast period of 2021-2031.
The neoantigen cancer vaccine market is projected to reach $1,988.5 million by 2031 from $35.5 million in 2024, at a compound annual growth rate (CAGR) of 77.73%.
The global cell-free DNA isolation and extraction market was valued at $169.9 million in 2020 and is expected to reach $735.1 million by 2031, witnessing a CAGR of 14.19% during the forecast period 2021-2031.
The global NGS sample preparation market is projected to reach $3,279.3 million by 2026, growing from $1,468.9 million in 2020, at a CAGR of 14.24% during the forecast period 2021-2026.
The global spine X-ray and computed tomography market was valued at $916.0 million in 2020 and is projected to reach $1,623.5 million by 2030.
The global ENT devices market was valued at $13,799.5 million in 2020 and is projected to reach $25,127.7 million by 2030.
The global pharmacogenomics services market is projected to reach $9,346.8 million by 2031 from $5,060.0 million in 2020, at a CAGR of 5.71% during the forecast period 2021-2031.
The global aseptic pharma processing market was valued to be $10,633.3 million in 2020 and is expected to reach $24,364.0 million by 2031, witnessing a CAGR of 7.90% during the forecast period 2021-2031.
The global NIPT market was valued at $2.52 billion in 2020 and is expected to reach $12.61 billion by 2031, registering a CAGR of 15.79% during the forecast period 2021-2031.
The global robotic-assisted imaging technologies market was valued at $617.7 million in 2020 and is projected to reach $2,207.8 million by the end of 2030, growing at a CAGR of 13.74% during the forecast period 2021-2030.
The global viral and non-viral vector manufacturing market was valued at $1.50 billion in 2020 and is expected to reach $27.03 billion by 2031, witnessing a CAGR of 18.54% during the forecast period 2021-2031.
The global carrier screening market is projected to reach $4,479.0 million by 2031, growing from $1,187.4 million in 2020, at a CAGR of 12.67% during the forecast period 2021-2031.
The global medical grade tubing market was valued at $4,407.7 million in 2020 and is anticipated to reach $6,255.9 million by the end of 2030, witnessing a CAGR of 3.70% during the forecast period 2021-2030.
The global CRISPR gene editing market was valued at $1,088.6 million in 2020 and is expected to reach $18,856.6 million by 2031, witnessing a CAGR of 29.60% during the forecast period 2021-2031.
In 2020, the global epigenetics market was valued at $2,434.6 million, and it is expected to reach $14,311.1 million by 2031, growing at a CAGR of 17.11% during the forecast period 2021-2031.
In 2020, the global cancer microbiome sequencing market was valued at $155.5 million, and it is expected to reach $1,216.2 million by 2031, growing at a CAGR of 20.01% during the forecast period 2021-2031.
The global next-generation biomanufacturing market is expected to grow at a CAGR of 14.85% during the forecast period 2021-2031 and is expected to reach a value of $85,201.2 million in 2031.
The global preimplantation genetic testing market was valued at $972.1 million in 2020 and is expected to reach $2,725.7 million by 2031, registering a CAGR of 9.69% during the forecast period 2021-2031.
The global positive airway pressure devices market report highlights that the market was valued at $3,411.5 million in 2020 and is expected to reach $6,218.5 million by the end of 2030.
The global molecular diagnostics market is projected to reach $24,228.0 million by 2031 from $10,914.6 million in 2020, at a CAGR of 7.38% during the forecast period 2021-2031.
The global surgical microscopes market was valued at $928.3 million in 2020 and is anticipated to reach $3,578.2 million by the end of 2031, growing at a CAGR of 13.3% during the forecast period 2021-2031.
The global interventional oncology devices market was valued at $2,429.2 million in 2020 and is projected to reach $7,861.1 million by the end of 2030.
The market for Europe hereditary genetic testing is predicted to grow at a CAGR of 13.34% during the forecast period 2021-2031.
The global transcriptomics market is projected to reach $33.68 billion by 2031 from $4.47 billion in 2020, at a CAGR of 20.11% during the forecast period 2021-2031.
The global constrained peptide drugs market is anticipated to be valued at $60.1 million in 2023 and is expected to reach $10,367.2 million by 2031, witnessing a CAGR of 90.37% during the forecast period 2023-2031.
The global pharmaceutical quality management software market report highlights that the market was valued at $472.6 million in 2020 and is expected to reach $3,717.7 million by the end of 2030.
The global imaging CRO market is expected to grow at a CAGR of 7.25% during the forecast period 2021-2031 and is expected to reach a value of $9,603.0 million in 2031.
The global organ transplant diagnostics market is projected to reach $9,663.0 million by 2031, growing from $3,100.3 million in 2020, at a CAGR of 10.92% during the forecast period 2021-2031.
The global biomaterials market was valued at $122.92 billion in 2020 and is expected to reach $725.88 billion by 2031, growing at a CAGR of 17.98% between 2021 and 2031.
The global urgent care apps market was valued at $973.6 million in 2020 and is expected to reach $10,150.5 million by the end of 2030.
The global nucleic acid therapeutics CDMO market was valued at $1,546.4 million in FY2020 and is estimated to reach $4,463.7 million by 2030.
The global minimally invasive surgical systems market is estimated to be valued at $27,882.8 million in 2020 and is anticipated to reach $55,716.7 million by the end of 2031, growing at a CAGR of 6.3% during 2021-2031.
The global AI-enabled X-Ray imaging solutions market was valued to be $66.0 million in 2020 and is anticipated to reach $639.7 million by 2031, witnessing a CAGR of 20.2% during the forecast period 2021-2031.
The global ophthalmic drug delivery devices market was valued at $295.4 million in 2020 and is anticipated to reach $537.8 million by the end of 2030, witnessing a CAGR of 6.17% during the forecast period 2021-2030.
The global advanced dermatology drug delivery devices market report highlights that the market was valued at $3,348.9 million in 2020 and is expected to reach $8,783.0 million by the end of 2030.
The global gel documentation systems market is projected to reach $411.1 million by 2030 from $275.4 million in 2020, at a CAGR of 4.04% during the forecast period 2021-2030.
The global liquid handling systems market was valued to be $3,210.2 million in 2020 and is expected to reach $7,128.1 million by 2031, witnessing a CAGR of 7.43% during the forecast period 2021-2031.
The global direct-to-consumer genetic testing market accounted for $1,155.9 million in 2020 and is expected to be $6,604.5 million by 2031.
The global non-invasive liquid biopsy market is projected to reach $9,470.3 million by 2031, growing from $1,096.9 million in 2020, at a CAGR of 20.38% during the forecast period 2021-2031.
The global industrial microbiological QC market is predicted to grow at a CAGR of 5.69% over the forecast period of 2021-2031.
The global electrocardiographs market report highlights that the market was valued at $4,394.1 million in 2020 and is expected to reach $9,826.8 million by the end of 2031.
The global nutrigenomics market is set to witness a CAGR of 17.26% during the forecast period 2021-2031.
The global urology care devices and platforms market report highlights that the market was valued at $13.61 billion in 2019 and is expected to reach $33.64 billion by the end of 2030.
The radiation therapy in oncology report highlights that the market was valued at $5,481.8 million in 2020 and is expected to reach $9,206.6 million by the end of 2031.
The radiofrequency-based aesthetic devices report highlights that the market was valued at $1,052.6 million in 2020 and is expected to reach $3,204.1 million by the end of 2030.
The global market for aseptic pharma processing equipment is predicted to grow at a CAGR of 7.29% over the forecast period 2021-2030.
The nucleic acid isolation and purification market is projected to reach $5,010.3 million by 2031 from $2,304.7 million in 2020, at a CAGR of 7.20%.
The global long-read sequencing market is projected to reach $3,305.5 million by 2030 from $504.7 million in 2020, at a CAGR of 21.15% during the forecast period 2021-2030.
The global AI in operating room market was valued at $67.8 million in 2020 and is anticipated to reach $2,951.5 million by the end of 2030.
The global market for flow cytometry in oncology is predicted to grow at a CAGR of 12.02% over the forecast period 2021-2031.
The global surgical instrument tracking devices market was valued at $354.3 million in 2020 and is anticipated to reach $868.2 million by 2031.
The global AI in neurology operating room market is projected to reach $692.8 million by 2030.
The global hemodynamic monitoring devices market was valued at $867.2 million in 2018 and is projected to reach $2,156.6 million by the end of 2030.
The global haptic feedback surgical environment market is expected to grow with a CAGR of 14.6% in terms of market value, during the forecast period 2021-2031.
The global market for mRNA vaccines and therapeutics for COVID-19 vaccines is predicted to decline at a CAGR of 13.50% over the forecast period of 2021-2025.
The global reproductive genetics market is predicted to grow at a CAGR of 12.38% over the forecast period 2021-2030.
The global next-generation ultrasound systems market was valued at $8,246.8 million in 2020 and is anticipated to reach $21,079.7 million by 2031.
The market for surgical robotics generated $5.46 billion in 2020, in terms of value and is estimated to reach $16.77 billion by 2031.
The global emerging mental health devices and platforms market is projected to reach $18,717.5 million by the end of 2030, witnessing a CAGR of 24.69% during the forecast period 2021-2030.
The global hybrid operating room market was valued at $826.9 million in 2019 and is expected to reach $2,520.7 million by the end of 2030.
The global home healthcare market was valued at $130.18 billion in 2019 and is anticipated to grow to $214.98 billion by the end of 2025.
The global market for in-vitro fertilization is predicted to grow at a CAGR of 9.37% over the forecast period 2020-2030.
The global oncolytic virus therapies market is predicted to grow at a CAGR of 26.28% over the forecast period 2020-2030.
The global market for regenerative medicines is predicted to grow at a CAGR of 13.99% over the forecast period of 2020-2030.
The global solid tumor testing market is projected to reach $40,660.6 million by 2030 from $22,504.1 million in 2020, at a CAGR of 6.09% during the forecast period 2020-2030.
The global SERD therapeutics market was valued at $1000.2 million in 2019 and is expected to reach $4085.0 million by 2030.
The global market for precision psychiatry is predicted to grow at a CAGR of 17.26% over the forecast period of 2021-2026.
The global digital respiratory devices market accounted for $13.1 million in 2019 and is expected to reach $405.1 million by 2030.
The global CDSS market was valued at $1.77 billion in 2019 and is expected to reach $3.74 billion by 2030.
Global Continuous Positive Airway Pressure Market to Reach $10,182.0 Million by 2026
The global cell and gene therapy drug delivery devices market was valued at $55.75 thousand in 2019, and is expected to reach $375.13 thousand by 2030.
The global market for somatic genetic testing is predicted to grow at a CAGR of 9.30% over the forecast period of 2020-2030.
The global industrial microbiology market was valued to be $5,604.2 million in 2019 and is expected to reach $13,181.2 million by 2030.
The global wireless brain sensors market is set to witness a CAGR of 10.53% between 2021 and 2030.
The global rare disease diagnostics market has been currently witnessing a rapid growth and is expected to continue to grow at a CAGR of 8.57% during the forecast period, 2020-2030.
The global market for cell and gene therapy manufacturing QC is predicted to grow at a CAGR of 22.80% over the forecast period of 2020-2030.
The global minimally invasive gastrointestinal surgical systems market was valued at $5,021.8 million in 2020 and is anticipated to reach $10,441.0 million by 2031.
The global AI in healthcare market is anticipated to reach $35,892.2 million by 2030, registering a CAGR of 24.40%, during the forecast period 2021-2030.
The global cell and gene therapy market was valued at $2,599.7 million in 2020, and it is expected to grow at an impressive double-digit rate of 33.82% and reach a value of $25,002.1 million in 2027.
The global single-cell multi-omics market is projected to reach $3,188.9 million by 2025 from $1,221.5 million in 2020, at a CAGR of 21.16% during the forecast period, 2020-2025.
The global CRISPR gene editing market was valued at $846.2 million in 2019 and is expected to reach $10,825.1 million by 2030.
The global market for Genomic data analysis and interpretation is predicted to grow at a CAGR of 10.21% over the forecast period of 2020-2030.
The radiation dose management market is expected to grow at a CAGR of 10.96% during the forecast period, 2021-2030.
The global market for radiofrequency-based devices is predicted to grow at a CAGR of 12.81% over the forecast period of 2021-2030.
The global 4K medical imaging market was valued at $822.1 million in 2019 and is anticipated to reach $2,399.9 million by 2030, growing at a CAGR of 12.2% during the forecast period 2020-2030.
The global single-use/disposable endoscopy market was estimated to be $471.7 million in FY2019, and it is expected to grow at a CAGR of 44.03% during the forecast period, 2021-2030.
The global market for MRD testing is predicted to grow at a CAGR of 15.64% over the forecast period of 2020-2025.
The global AI-enabled medical imaging solutions market was valued at $636.1 million in 2019 and is anticipated to reach $10,145.1 million by 2030, growing at a CAGR of 26.69%, during the forecast period 2020-2030.
The global market for microbiome therapeutics is predicted to grow at a CAGR of 25.64% over the forecast period of 2020-2030.
The global oncology precision medicine market was valued at $46.90 billion in 2019, and it is expected to grow at an impressive double-digit rate of 11.21% and reach a value of $148.66 billion in 2030.
The global bioengineered skin substitutes market was valued at $1.31 billion in 2019 and is expected to reach $4.33 billion by 2030.
The global market for CAR T-cell therapy is predicted to grow at a CAGR of 44.79% over the forecast period 2020-2030.
The spatial genomics and transcriptomics market to be one of the most rapidly evolving markets, which is predicted to grow at a CAGR of 23.20% during the forecast period of 2020-2030.
The overall market was $5,681.1 million in FY2019, and it is expected to grow at a CAGR of 6.17% during the forecast period, 2021-2030.
The global digital surgery technologies market was valued at $252.5 million in 2019 and is anticipated to reach $5,110.5 million by 2030, growing at a CAGR of 32.1% during the forecast period 2020-2030.
The global advanced balloon catheter market was estimated to be $2,523.9 million in FY2019, and it is expected to grow at a CAGR of 6.25% during the forecast period, 2021-2030.
The global market for autoimmune disorder drug delivery devices is predicted to grow at a CAGR of 15.25% over the forecast period of 2020-2030.
The global minimally invasive neurosurgical systems market was valued at $419.8 million in 2019 and is anticipated to reach $1,217.4 million by 2030, growing at a CAGR of 11.9% during the forecast period 2020-2030.
The global market for COVID-19 diagnostic testing is predicted to grow at a CQGR of 23.50% over the forecast period of 3Q2020-4Q2021.
The global femtech market was valued at $560.5 million in 2018 and is expected to be valued at $4,692.3 million, by the end of 2030.
The global non-oncology precision medicine market was valued at $41.1 billion in 2019, and it is expected to grow at an impressive double-digit rate of 11.03% and reach a value of $129.96 billion in 2030.
The global market for neurodegenerative disorder therapeutics is predicted to grow at a CAGR of 7.21% over the forecast period of 2020-2030.
The population sequencing market is projected to reach $64,047.6 million by 2030 from $21,730.4 million in 2020, at a CAGR of 11.41% during the forecast period, 2020-2030.
The global liquid biopsy market is projected to reach $12,933 million by 2030 from $2588.6 million in 2019, at a CAGR of 15.87% during the forecast period 2020-2030.
By volume, global NIPT market was 3.14 million units in 2019 and is expected to reach 23.58 million units by 2030.
The global AI-enabled imaging modalities market was valued at $214.4 million in 2019 and is anticipated to reach $2,649.6 million by 2030.
The India telemedicine market was valued at Rs 380.22 crores in 2019, and is expected to be valued at Rs 1,765.56 crores, by the end of 2025.
The global market for PD-1/PD-L1 immunotherapy is predicted to grow at a CAGR of 10.72% over the forecast period of 2020-2030.
The global emerging sleep apnea devices and platforms market was estimated to be $4,882.2 million in FY2019, and it is expected to grow at a CAGR of 9.94% during the forecast period, 2021-2030.
The global precision medicine market is set to witness a CAGR of 11.13% during the period between 2020 and 2030.
The global market for digital PCR (d-PCR) is predicted to grow at a CAGR of 17.57% over the forecast period of 2020-2025.
The global healthcare service robots market was valued to be $462.3 million in 2019 and is anticipated to witness an impressive double-digit growth rate, to reach $2.82 billion by 2025.
The global market for DNA damage response drugs is predicted to grow at a CAGR of 21.33% over the forecast period of 2020-2030.
The global telemedicine market was estimated to be $21.55 billion in 2019. It is anticipated to reach a value of $123 billion by the end of 2030.
The Global Point-of-Care Imaging Devices Market was valued to be $8.66 billion in 2019 and is anticipated to witness an impressive double-digit growth rate, to reach $19.84 billion by 2030.
The global pediatric genetic testing market is expected to grow at a double-digit compound annual growth rate of 14.30% in the forecast period 2020-2030.
The global market size of the surgical robotics market is estimated to have been $4.71 billion in 2018 and is expected to reach $15.43 billion by 2029.
The global neurostimulation devices market is set to witness a CAGR of 8.87% during the period between 2021 and 2030.
The global market for IVD is predicted to grow at a CAGR of 5.06% over the forecast period of 2020-2030.
The global market for infectious disease biomarker testing market is predicted to grow at a CAGR of 14.48% during the forecast period of 2020-2030.
The global next-generation surgical robotics market is expected to grow with a robust CAGR of 44.6% during the forecast period, 2020-2030.
The global skin microbiome modulators market was valued at $541.1 million in 2019 and is anticipated to grow over $2,971.6 million by 2030.
The global genetic counseling market was valued at $972.2 million in 2019 and is anticipated to grow over $4,079.3 million by 2030.
The global DNA methylation market is predicted to grow at a CAGR of 15.70% over the forecast period of 2020-2030.
The global market for hereditary genetic testing is predicted to grow at a CAGR of 13.59% over the forecast period of 2020-2030.
The global ventilator market is witnessing an exponential rise in the size of the market due to the ongoing COVID-19 pandemic.
The global market for infectious disease rapid diagnostics is predicted to grow at a CAGR of 12.36% over the forecast period of 2020-2025.
As of 2019, the global Femtech market was estimated to be $820.6 million and is anticipated to grow with a double digit CAGR of 12.65% during the forecast period.
The U.S. solid tumor testing market is projected to reach $15,396.4 million by 2030 from $8,179.7 million in 2019, at a CAGR of 5.91% during the forecast period 2020-2030.
In 2019, the market size of the global tumor genomics market was valued at $8,131.0 million, and is expected to reach $16,287.2 million in 2028, registering a CAGR of 8.09% during the forecast period between 2020-2028.
Our healthcare experts are continuously analysing the impact of regulatory and industrial decisions on the global ventilator market. Moreover, the global market for ventilators is predicted to grow at an exponential CAGR of 176% by the end of 2020.
The global market for whole genome and exome sequencing is predicted to grow at a CAGR of 26.94% over the forecast period of 2019-2029.
Global Viral Vector and Plasmid Manufacturing Market to Reach $5.86 Billion by 2030.
The global tissue imaging market was valued to be $14.42 billion in 2019 and is anticipated to witness an impressive double-digit growth rate, to reach $37.44 billion by 2030.
The global companion diagnostics market to grow at a significant CAGR of 12.45% during the forecast period, 2020-2030.
The global non-invasive drug delivery devices market was valued at $548.5 million in 2018 and is anticipated to reach $2,354.4 million by 2025.
The global ventilator market is witnessing an exponential rise in the size of the market due to the ongoing COVID-19 pandemic. The overall market was estimated to be $1,072 million in 2018, and it was expected to grow at a CAGR of 7.1% in the pre-COVID scenario by the end of 2026.
The Global Medical Devices Testing Services Market Report by BIS Research projects the market to grow at a significant CAGR of 10.81% during the forecast period, 2019-2029.
The nucleic acid isolation and purification industry analysis by BIS Research projects the market to grow at a significant CAGR of 5.98% during the forecast period, 2020-2029.
Global clinical biomarkers market analysis by BIS Research projects the market to grow at a significant CAGR of 10.07% during the forecast period, 2019-2029.
The Global Human Microbiome Sequencing Market Report by BIS Research projects the market to grow at a significant CAGR of 19.44% during the forecast period, 2019-2029.
The Global Minimally Invasive Surgical Systems Market Report by BIS Research projects the market to grow at a significant CAGR of 6.51% during the forecast period, 2020-2030.
Global OR Communication Market by BIS Research projects the market to grow at a significant CAGR of 7.71% during the forecast period 2019-2025.
The Global AI-Enabled Drug Discovery and Clinical Trials Market Report by BIS Research projects the market to grow at a significant CAGR of 24.88% during the forecast period from 2019 to 2030.
The global virtual diagnostics market industry analysis by BIS Research projects the market to grow at a significant CAGR of 15.52% during the forecast period, 2019-2030.
The Global Bioremediation Market report by BIS Research projects the market to grow at a significant CAGR of 7.72% during the forecast period from 2019 to 2028.
The Global Digital Biomarkers Market Report by BIS Research projects the market to grow at a significant CAGR of 40.39% during the forecast period from 2019 to 2025.
The RNA sequencing industry analysis by BIS Research projects the market to grow at a significant CAGR of 14.21% during the forecast period, 2019-2028.
The U.S. hematologic malignancies market analysis by BIS Research projects the market to grow at a significant CAGR of 14.60% during the forecast period, 2019-2025.
The minimally invasive biopsy technologies market industry analysis by BIS Research projects the market to grow at a significant CAGR of 12.82% during the forecast period, 2019-2030.
The Global Next-Generation Biomanufacturing Market Report by BIS Research projects the market to grow at a significant CAGR of 10% during the forecast period, 2019-2029.
The single cell sequencing industry analysis by BIS Research projects the market to grow at a significant CAGR of 15.24% during the forecast period, 2019-2029.
The Global Robotic Surgery Consumables Market Report by BIS Research projects the market to grow at a significant CAGR of 11.37% during the forecast period, 2020-2030.
The in-silico drug discovery industry analysis by BIS Research projects the market to grow at a significant CAGR of 12.92% during the forecast period, 2019-2029.
The Global Electronic Skin Patches industry analysis by BIS Research projects the market to grow at a significant CAGR of 17.22% during the forecast period, 2019-2024.
Global Advanced Power Solutions for Implantable and Wearable Medical Devices Market by BIS Research projects the market to grow at a significant CAGR of 6.26% during the forecast period 2019-2029.
The global oncology informatics market to grow at a significant CAGR of 7.03% during the forecast period from 2019 to 2025.
The global neoantigen cancer vaccine market to grow at a significant CAGR of 34.69% during the forecast period, 2023-2030.
The global microfluidics market to grow at a significant CAGR of 13.73% during the forecast period, 2019-2029.
The global recombinant cell culture supplements market to grow at a significant CAGR of 12.93% during the forecast period, 2019-2029.
The global roboticare market was valued to be $408.6 million in 2018 and is projected to grow at a CAGR of 18.27% from 2019 to 2029.
The global patient monitoring solutions market to grow at a significant CAGR of 6.50% during the forecast period from 2019 to 2028.
The global next-generation visualization and navigation systems market was valued at $1.08 billion in 2018 and is anticipated to reach $4.34 billion by 2029, growing at a CAGR of 13.08% during the forecast period 2019-2029.
The global photoacoustic imaging market to grow at a significant CAGR of 28.88% during the forecast period, 2019-2029.
The global hematology testing market was valued to be $4.54 billion in 2018 and is anticipated to witness an impressive single-digit growth rate, to reach $XX billion by 2029.
The Global Interoperability Solutions in Healthcare Market Report by BIS Research projects the market to grow at a significant CAGR of 5.9% during the forecast period from 2019 to 2025.
The hematologic malignancies testing industry analysis by BIS Research projects the market to grow at a significant CAGR of 15.24% during the forecast period, 2019-2025.
The global molecular forensics market has been currently witnessing a rapid growth and is expected to continue to grow with a CAGR of 9.09% during the forecast period, 2019-2029.
The global holographic imaging market is expected to register a CAGR of 35.9% during the forecast period 2019-2029.
Human Microbiome Therapeutics Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 33.00% during the forecast period 2019-2029.
The global bioelectric medicine market to grow at a significant CAGR of 6.41% during the forecast period, 2019-2025.
Radiation Therapy Quality Assurance Phantoms Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 4.59% during the forecast period 2019-2024.
The Global Patient Engagement Solutions Market report by BIS Research projects the market to grow at a significant CAGR of 14.09% during the forecast period from 2019 to 2028.
The NGS sample preparation industry analysis by BIS Research projects the market to grow at a significant CAGR of 15.54% during the forecast period, 2019-2025.
Interventional Oncology Devices Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 9.0% during the forecast period 2019-2025.
The global blockchain in genomic market analysis by BIS Research projects the market to grow at a significant CAGR of 66.42% during the forecast period, 2019-2029.
The advanced prosthetics and exoskeleton market was valued to be $2.11 Billion in 2018 and is estimated to reach a market value of $3.82 Billion by 2024 at a CAGR of 10.42% from 2019 to 2024.
The global surgical robotics market is anticipated to grow at a robust CAGR of 10.7% during the forecast period 2019-2029.
The AI-enabled medical imaging solutions market to grow at a significant CAGR of 30.95% during the forecast period, 2019-2029.
The global molecular diagnostic point of care industry analysis by BIS Research projects the market to grow at a significant CAGR of 12.14% during the forecast period, 2019-2029.
The global radiation dose management industry analysis by BIS Research projects the market to grow at a significant CAGR of 12.22% during the forecast period, 2019-2025.
The global robotic surgical simulation systems market was valued to be $276.5 million in the year 2018 and is anticipated to witness an impressive double-digit growth rate, to reach $1.03 Billion by 2024.
The Global Chatbots in Healthcare Market Report by BIS Research projects the market to grow at a significant CAGR of 26.29% during the forecast period from 2019 to 2029.
The Global Operating Room Management Solutions Market Report by BIS Research projects the market to grow at a significant CAGR of 6.4% during the forecast period from 2019 to 2029.
The global advanced wound care market, by products, was valued to be $8,904.6 million in 2018 and is estimated to reach a market value of $11,059.3 million by 2024.
The global stem cell therapy market to grow at a significant CAGR of 27.99% during the forecast period, 2019-2029.
The global NGS based monitoring and diagnostic test market to grow at a significant CAGR of 18.08% during the forecast period, 2019-2028.
The global mobile C-Arm market was valued to be $1.03 billion in 2018 and is expected to reach $1.85 billion by 2029, witnessing a CAGR of 5.16% in the forecast period 2019-2029.
The global molecular imaging market market was valued at approximately $6.84 billion in 2018 and is anticipated to reach $11.13 billion by 2028.
The aim of the population genomic initiatives implemented across the globe is to develop the biobank of genomic datasets facilitating the understanding of interaction between the gene and the phenotypic expression.
In 2018, the global non-opioid pain relief device market was estimated to be $3,674 million and it is expected to reach a value of $8,778.9 million by the end of 2029..
The cell and gene therapy Industry analysis by BIS Research projects the market to grow at a significant CAGR of 36.52% during the forecast period, 2019-2025.
The China Precision Medicine Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 12.82% during the forecast period, 2019-2029.
The Global Spinal Fusion Devices Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 5.40% during the forecast period of 2019 to 2028.
The global ventricular assist devices and artificial heart systems market was estimated at $2.20 billion in 2018 and is anticipated to reach $2.69 billion by 2023.
The Global Oligonucleotide Synthesis Industry Analysis by BIS Research projects the market to grow at a significant CAGR of 11.02% during the forecast period from 2019 to 2029.
The global carrier screening market was valued at $846.9 million in 2018 and is estimated to grow over $2.93 billion by 2029.
The Global Clinical Decision Support Systems Market Report by BIS Research projects the market to grow at a significant CAGR of 8.3% during the forecast period from 2019 to 2028.
The global digital respiratory devices market was valued at approximately $8.5 million in 2018 and is anticipated to reach $334.0 million by 2029.
The global single cell multi-omics industry analysis by BIS Research projects that the market was valued at $1.83 billion in 2018 and is anticipated to generate a value of $5.32 billion by 2025.
The Global OR Visualization Systems Market Report by BIS Research projects the market to grow at a significant CAGR of 6.52% during the forecast period from 2019 to 2025.
The North America cannabis industry analysis by BIS Research highlights that the market was valued at $13.21 billion in 2018 and is expected to reach $36.7 billion in 2025.
The Asia-Pacific IVF market is valued at $6.99 billion in 2018, and is expected to witness a CAGR of 10.13% during the forecast period between 2019 and 2029.
The global pharmacogenomics market has been witnessing a steady growth since the end of the Human Genome Project in 2003. The market is expected to continue to grow with a double digit CAGR of 6.98% during the forecast period, 2019-2028.
The global hearing aids market was estimated at $8.37 billion in 2018 and is anticipated to reach $16.34 billion by 2028.
The global direct-to-consumer market was valued at approximately $824.1 million in 2018 and is anticipated to reach $6,364.5 million by 2028.
The global neurostimulation devices market has been witnessing annual growth rate of approximately 13.14% in past three years (2015-2018), and the market is expected to continue to grow with the CAGR of 9.23% during the forecast period, 2019-2024.
The global sports medicine market was estimated to be $5.99 billion in 2018 and is expected to be $9.25 billion by 2026. It is expected to grow at a CAGR of 5.64% from 2019 to 2026.
In 2018, the global next-generation sequencing market was valued at $4.93 billion and is anticipated to grow at a CAGR of 13.18% in the forecast period 2019-2024.
The global phototherapy devices market was valued at approximately $682.3 million in 2018 and is anticipated to reach $1.07 billion by 2028.
The global Augmented Reality and Virtual Reality market has been witnessing a steady growth. The market is expected to grow with a double digit CAGR of 23.13% during the forecast period, 2019-2025.
The global healthcare IoT security market is expected to continue to grow with a double digit CAGR of 41.38% during the forecast period 2019-2028.
The global OR integration systems market is expected to continue to grow with a single digit CAGR of 7.1% during the forecast period, 2019-2025.
The Latin America cell culture market has been witnessing a steady growth. The market is expected to continue to grow with a single digit CAGR of 6.20% during the forecast period, 2018-2025.
The global anti-aging devices market was estimated at $6.37 billion in 2017 and is anticipated to reach $15.77 billion by 2028.
The global industrial microbiological QC market is expected to continue to grow with a single digit CAGR of 6.22% during the forecast period, 2019-2028.
The Latin America cell analysis market is anticipated to reach $1,566.7 million by 2025, witnessing a CAGR of 10.29% in the forecast period 2019-2025.
The Latin America liquid biopsy market is anticipated to reach $70.9 million by 2025, witnessing a CAGR of 10.29% in the forecast period 2019-2025.
The global cancer immunotherapy market was valued at $39.86 billion in 2017 and is anticipated to reach $170.70 billion by 2028.
The global teleradiology services market was valued $2.63 billion in 2017 and is expected to grow at a CAGR of 15.06% during the forecast period between 2018 and 2026.
The global precision medicine market is anticipated to reach $216.75 billion by 2028, witnessing a CAGR of 10.64% in the forecast period 2018-2028.
The global molecular diagnostics market has been witnessing a steady growth since the end of the Human Genome Project in 2003. The market is expected to continue to grow with a double digit CAGR of 10.89% during the forecast period, 2018-2028.
The global healthcare robotics market was estimated at $5.40 billion in 2017 and is anticipated to reach $11.44 billion by 2023.
The global portable imaging solutions market is expected to reach $5.74 billion by 2028.
The global artificial organs market was estimated at $1.6 billion in 2017 and is anticipated to reach $5.37 billion by 2023.
The global mammography system market is expected to reach $3.51 billion by 2028.
The global recombinant cell culture supplements market was valued $230.5 million in 2017 and is anticipated to reach $788.6 million by 2028.
The global human microbiome modulators market has been witnessing a steady annual growth rate of approximately 6.08% in past three years (2015-2017), and the market is expected to continue to grow with a double digit CAGR of 16.29% during the forecast period, 2018-2023.
The global vaccine market is anticipated to reach $103.57 billion by 2028, witnessing a CAGR of 11.02% in the forecast period 2018-2028.
The global nanopharmaceutical drug market is valued $40.37 billion in 2017 and is expected to reach $79.29 billion by 2026.
As of 2017, the global joint reconstruction market was estimated to be $16.82 billion and is expected to reach a value of $26.81 billion by the end of 2025, growing with a double digit CAGR during the forecast period.
The global rare disease diagnostics market was valued $45.18 billion in 2017 and is anticipated to reach $86.15 billion by 2025.
The global surgical robotics market is expected to reach $11.65 billion by 2025. The market consists of various product segments such as surgical systems, instruments and accessories and maintenance services.
As of 2019, the global NGS informatics and clinical genomics market was estimated to be approximately $957.0 million and is expected to reach a value of an estimated $5,016.0 million by the end of 2028.
The global enzymes market was valued $6.57 billion in 2017 and is anticipated to reach $10.63 billion by 2025.
The global image guided interventions market is expected to reach $6,509.3 million by 2028.
The global interventional cardiology market was estimated at $14.69 billion in 2017 and is anticipated to reach $24.96 billion by 2027.
The global liquid biopsy market is anticipated to reach $2.94 billion by 2028, witnessing a CAGR of 14.45% in the forecast period 2018-2028.
The global CDx market is expected to continue to grow with a double digit CAGR of 21.38% during the forecast period, 2018-2025.
The total addressable market size for laparoscopic and endoscopic devices market was $17.78 billion in the year 2016 and is expected to reach about $27.92 billion by the end of 2025.
In 2017, the global precision medicine market accounted for $48.9 billion, which is expected to reach ~$70 billion by 2020 with effective implementation of several novel technologies.
The global ambulatory device market is expected to reach $17.55 billion by 2028.
The global orthodontics market is expected to reach $7.47 billion by 2025.
The global radiofrequency-based devices market for lower back pain is expected to reach $444.4 million by 2026.
Overall in 2017 the global minimally invasive surgical systems market value was estimated at $23.95 billion, which is estimated to grow over $40.52 billion by 2025.
The global metastatic cancer treatment market was valued $54.11 billion in 2017, and is anticipated to reach $98.24 billion by 2025.
The global bioprinting market is expected to reach $4.70 billion by 2025 from $1.07 billion in 2016, at the CAGR of 15.2% during the forecast period, 2018-2025.
The global cell free DNA isolation and extraction market was valued at $81.7 million in 2016, and is anticipated to reach $442.8 million by 2026.
The global medical lighting technologies market is expected to account for $2.76 billion by 2026.
The global injectable drug delivery market was estimated at $16.73 billion in 2016 and is estimated to grow over $37.47 billion by 2025.
The global biosensors market was valued at $1.46 billion in 2017 and is anticipated to reach $3.90 billion in 2027, registering a CAGR of 10.34% in the forecast period 2018-2027..
The blockchain in healthcare market is estimated to amount to $176.8 million in 2018 and is expected to grow at a CAGR of 63.85% from 2018 to 2025.
The global CRISPR technology market is expected to reach $10.55 billion by 2027.
The global electrosurgical devices market was estimated at $2.64 billion in 2016 and is anticipated to reach $4.33 billion by 2023.
The global POCT market was estimated at $13.87 billion in 2017 and is estimated to grow over $23.92 billion by 2026.
The global big data in healthcare market was estimated to be worth $14.25 billion in 2017, and is expected to grow over $68.75 billion by 2025.
The global medical assistive technologies market is expected to grow over $24.41 Billion by 2025.
